MARKET

PMD

PMD

Psychemedics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.260
-0.040
-0.93%
Opening 11:34 11/25 EST
OPEN
4.290
PREV CLOSE
4.300
HIGH
4.328
LOW
4.260
VOLUME
2.75K
TURNOVER
--
52 WEEK HIGH
10.69
52 WEEK LOW
3.580
MARKET CAP
23.54M
P/E (TTM)
-6.1172
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Psychemedics reports Q3 results
Psychemedics (PMD): Q3 Non-GAAP EPS of -$0.07; GAAP EPS of -$0.20.Revenue of $5.17M (-47.5% Y/Y)Press Release
Seekingalpha · 11/09 22:36
Psychemedics Q3 EPS $(0.20) Down From $0.12 YoY, Sales $5.20M Down From $9.90M YoY
Psychemedics (NASDAQ:PMD) reported quarterly losses of $(0.20) per share. This is a 266.67 percent decrease over earnings of $0.12 per share from the same period last year. The company reported $5.20 million in sales
Benzinga · 11/09 22:31
Praxis Precision Medicines Readies $126 Million IPO
Praxis Precision Medicines has filed proposed terms for its U.S. IPO.The firm is developing treatments for various central nervous system and other disorders.PRAX has demonstrated positive early efficacy results, so for life science investors, the IPO is worth a close look.
Seekingalpha · 10/11 15:35
Psychemedics reports Q2 results
Psychemedics (PMD): Q2 GAAP EPS of -$0.37.Revenue of $3.31M (-64.4% Y/Y)Press Release
Seekingalpha · 08/12 21:26
Cannabis Stock Gainers And Losers From July 30, 2020
Gainers Australis Capital (OTC: AUSAF) shares closed up 19.92% at $0.15 Next Green Wave Holdings (OTC: NXGWF) shares closed up 15.31% at $0.21
Benzinga · 07/30 21:44
Does Psychemedics Corporation's (NASDAQ:PMD) CEO Pay Matter?
Simply Wall St. · 05/28 14:02
Psychemedics reports Q1 results
Psychemedics (NASDAQ:PMD): Q1 GAAP EPS of -$0.03. Revenue of $7.5M (-23.6% Y/Y) Press Release
seekingalpha · 05/14 02:20
Psychemedics Announces First Quarter Results
GlobeNewswire · 05/13 22:15
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PMD. Analyze the recent business situations of Psychemedics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
Institutional Holdings
Institutions: 57
Institutional Holdings: 2.70M
% Owned: 48.91%
Shares Outstanding: 5.53M
TypeInstitutionsShares
Increased
4
28.90K
New
5
-28.05K
Decreased
16
332.13K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
-0.40%
Healthcare Providers & Services
-1.14%
Key Executives
Chairman/Director/President/Chief Executive Officer
Raymond Kubacki
Executive Vice President
Charles Doucot
Vice President - Finance/Treasurer/Assistant Secretary
Neil Lerner
Vice President - Operations
Michael Schaffer
Independent Director
A. Clinton Allen
Independent Director
Harry Connick
Independent Director
Walter Tomenson
Independent Director
Fred Weinert
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
02/11/2020
Dividend USD 0.18
02/20/2020
10/22/2019
Dividend USD 0.18
11/04/2019
07/23/2019
Dividend USD 0.18
08/05/2019
04/23/2019
Dividend USD 0.18
05/06/2019
03/04/2019
Dividend USD 0.18
03/13/2019
10/23/2018
Dividend USD 0.18
11/01/2018
07/24/2018
Dividend USD 0.18
08/06/2018
04/24/2018
Dividend USD 0.18
05/07/2018
03/07/2018
Dividend USD 0.15
03/16/2018
10/24/2017
Dividend USD 0.15
11/03/2017
08/02/2017
Dividend USD 0.15
08/10/2017
04/25/2017
Dividend USD 0.15
05/04/2017
02/06/2017
Dividend USD 0.15
02/14/2017
10/26/2016
Dividend USD 0.15
11/03/2016
07/26/2016
Dividend USD 0.15
08/03/2016
04/26/2016
Dividend USD 0.15
05/04/2016
02/10/2016
Dividend USD 0.15
02/18/2016
10/28/2015
Dividend USD 0.15
11/05/2015
07/28/2015
Dividend USD 0.15
08/05/2015
04/27/2015
Dividend USD 0.15
05/06/2015
02/10/2015
Dividend USD 0.15
02/19/2015
10/30/2014
Dividend USD 0.15
11/06/2014
07/28/2014
Dividend USD 0.15
08/05/2014
04/29/2014
Dividend USD 0.15
05/07/2014
02/10/2014
Dividend USD 0.15
02/19/2014
10/28/2013
Dividend USD 0.15
11/06/2013
08/05/2013
Dividend USD 0.15
08/13/2013
05/07/2013
Dividend USD 0.15
05/15/2013
02/25/2013
Dividend USD 0.15
03/05/2013
11/05/2012
Dividend USD 0.15
11/13/2012
08/07/2012
Dividend USD 0.15
08/15/2012
05/08/2012
Dividend USD 0.15
05/16/2012
02/23/2012
Dividend USD 0.15
03/01/2012
11/03/2011
Dividend USD 0.12
11/15/2011
08/10/2011
Dividend USD 0.12
08/18/2011
05/05/2011
Dividend USD 0.12
05/12/2011
--
Dividend USD 0.12
03/09/2011
--
Dividend USD 0.12
11/23/2010
--
Dividend USD 0.12
09/01/2010
05/11/2010
Dividend USD 0.12
06/03/2010
02/23/2010
Dividend USD 0.12
03/03/2010
11/04/2009
Dividend USD 0.12
12/01/2009
--
Dividend USD 0.12
09/02/2009
--
Dividend USD 0.17
06/03/2009
--
Dividend USD 0.17
03/04/2009
--
Dividend USD 0.17
12/02/2008
--
Dividend USD 0.17
09/03/2008
--
Dividend USD 0.17
06/04/2008
--
Dividend USD 0.15
03/05/2008
--
Dividend USD 0.15
11/29/2007
More
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About PMD
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Psychemedics Corp. stock information, including NASDAQ:PMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PMD stock methods without spending real money on the virtual paper trading platform.